|
|||||
|
|
The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex) |
|
| Authors: | Wynn R L |
| Affiliation: | Department of Oral-Craniofacial Biological Sciences, Dental School, University of Maryland at Baltimore, USA. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |